TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

LENSAI

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

LENSAI

ST13

US500000079408263

Classe

9, 10, 42

Pedido

79408263

Registro

7954131

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

26

Atualização mais recente

24/04/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

9, 10, 42

Data de depósito

13/05/2024

Data de registro

23/09/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

23/09/2025

Última transação

24/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

5

Tipo de titular

26

Localização do titular

BE

Examinador

CORNWELL, ANDREA B

Unidade examinadora

M60

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Biostrand

Representantes

Clifford D. Hyra Fresh IP PLC

Classificação técnica

Classes Nice

Classe 9Classe 10Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Downloadable and recorded software for the analysis of biological samples, genetical, protein or sequence related data; downloadable and recorded software relating to the biological, biotechnological, pharmaceutical, medical, veterinary, agricultural, and food technology research fields for the analysis of biological samples, genetical, protein or sequence related data; downloadable and recorded software for the characterization of biopolymers, biological samples and biological particles; scientific research and laboratory apparatus for the analysis of biological samples, genetical, protein or sequence related data, namely, laboratory devices for detecting genetic sequences and corresponding downloadable and recorded operating system software; laboratory apparatus and instruments for the analysis of biological samples, genetical, protein or sequence related data, namely, biological microscopes and corresponding downloadable and recorded operating system software; biometric identification apparatus for laboratory purposes, namely, biometric scanners, and corresponding downloadable and recorded operating system software; downloadable cloud-based software for storing and managing electronic data in the field of biological sequence data and data linked thereto; downloadable cloud-based software for structuring, clustering, manipulating, processing and ranking data relating to the biological, biotechnological, pharmaceutical and medical research field; downloadable cloud-based software for the analysis of biological samples, genetic, protein and sequence related data; downloadable cloud-based software, for the characterization of biopolymers, biological samples and biological particles; scientific research and laboratory apparatus, namely, DNA, RNA and protein sequencers and corresponding recorded operating system software sold as a unit; devices, namely, DNA, RNA and protein sequencers for analyzing biological samples, genetical, protein or sequence related data used as scientific laboratory apparatus and related downloadable operating system software; diagnostic apparatus for biological research and laboratory use, namely, DNA, RNA and protein sequencers and downloadable operating system software sold as a unit; instruments for scientific laboratory use, namely, DNA, RNA and protein sequencers and downloadable operating system software sold as a unit

Classe 10

Medical apparatus and instruments for use in biological, biotechnological, pharmaceutical and medical fields, namely, medical diagnostic apparatus for testing DNA, RNA and protein samples for medical and veterinary diagnostics, examination and monitoring of biological samples, genetical, protein or sequence related data; medical apparatus and instruments for testing DNA, RNA and protein samples, namely, DNA, RNA and protein sequencers to identify the microbiological makeup and profile of a subject for medical diagnostic purposes; medical apparatus and instruments for testing DNA, RNA and protein samples, namely, DNA, RNA and protein sequencers for the characterization of biopolymers, biological samples and biological particles for medical diagnostic purposes; apparatus for analyzing biological samples, genetical, protein or sequence related data for medical use, namely, DNA, RNA and protein sequencers for testing DNA, RNA and protein samples for medical diagnostic purposes

Classe 42

Scientific and technological services as well as research and design relating thereto, namely, the development of a cloud-based software program to perform genetic research by applying algorithmic principles for the quick retrieval of biological sequence data on all molecular layers to enable analysis of big data and by applying algorithms for structural search and modelling; biological research laboratory services; biological research and analysis, and development of biological samples, genetical, protein or sequence related data for medical use; biological research laboratory services, namely, sequencing of biological samples, including DNA and RNA and analysis thereof; biological research, development and analysis of biological samples, including DNA and RNA; biological research, namely, identification and characterization of biopolymers, biological samples, biological sequences and biological particles; scientific and technological services, namely, scientific research, analysis and testing in the field of biology, biotechnology, genetics, pharmacy and medicine; biological research and analysis, and development of biotechnology; biological analysis of biological samples, genetical, protein or sequence related data for medical use; Software-as-a-service (SAAS) services featuring software to perform genetic research and analysis by applying algorithmic principles for quick retrieval of biological sequence data on all molecular layers to enable analysis of big data and by applying algorithms for structural search and modelling

Publicações

Histórico de despachos e eventos da marca no USPTO.

26 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

23/04/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

16/04/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/04/2026

FIMP

FINAL DISPOSITION PROCESSED

02/04/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

30/03/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

29/03/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

23/12/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

23/09/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

23/09/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/08/2025

PUBO

PUBLISHED FOR OPPOSITION

05/08/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

30/07/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/07/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/06/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/06/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/06/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

28/02/2025

RFNT

REFUSAL PROCESSED BY IB

05/01/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

13/12/2024

RFRR

REFUSAL PROCESSED BY MPU

13/12/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

28/11/2024

CNRT

NON-FINAL ACTION WRITTEN

27/11/2024

DOCK

ASSIGNED TO EXAMINER

26/11/2024

MAFR

APPLICATION FILING RECEIPT MAILED

04/11/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/11/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

31/10/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace LENSAI ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.